Infantile hypotonia with failure to thrive

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Pompe disease, also known as glycogen storage disease type II (GSDII), is a rare inherited metabolic disorder.
• It is caused by a deficiency in the enzyme acid alpha-glucosidase, leading to the buildup of glycogen in lysosomes.
• This accumulation primarily affects cardiac and skeletal muscles, with varying severity across different age groups.

Purpose of the Study:

• To highlight the clinical presentation of infantile Pompe disease.
• To emphasize the importance of early diagnosis and clinical suspicion.
• To discuss current treatment options for Pompe disease.

Main Methods:

• Case report of an infant diagnosed with Pompe disease.
• Clinical observation of symptoms including hypotonia and failure to thrive.
• Discussion of diagnostic tools such as growth parameter plotting and developmental screening.

Main Results:

• The case presented demonstrates infantile Pompe disease identified at a routine four-month well visit.
• Early detection was facilitated by the presence of key clinical indicators.

Conclusions:

• Pompe disease diagnosis can be achieved through accurate clinical assessments, including growth monitoring and developmental screening.
• Enzyme replacement therapy is currently the sole medical intervention available for Pompe disease.
• A high index of suspicion is crucial for timely diagnosis and management of Pompe disease.